Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Hernando

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Science (New York, N.Y.)|November 1, 2008
Cancer. Aneuploidy advantages?Eva Hernando
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2018
Characterization of MicroRNAs Regulating FOXO ExpressionDoug Hanniford, Eva Hernando
Nature Cell Biology|November 1, 2017
TYRP1 mRNA goes fishing for miRNAs in melanomaMaria S Soengas, Eva Hernando
Oncoimmunology|August 31, 2012
miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cellsAvital Gaziel-Sovran, Eva Hernando
Disease Models & Mechanisms|September 3, 2025
Modeling metastasis - leveraging novel tools to streamline discovery in advanced cancerNicole M Eskow, Eva Hernando
Cancers|December 11, 2022
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted TherapiesAndrey Rubanov, Pietro Berico, Eva Hernando
Cytometry|November 28, 2002
Separation of live cells in different phases of the cell cycle for gene expression analysisGloria Juan, Eva Hernando, Carlos Cordon-Cardo
Frontiers in Oncology|June 11, 2013
In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain MetastasisAvital Gaziel-Sovran, Iman Osman, Eva Hernando
Cancer|August 27, 2015
Revisiting determinants of prognosis in cutaneous melanomaSarah A Weiss, Douglas Hanniford, Eva Hernando, et al.
Cell Cycle (Georgetown, Tex.)|March 8, 2013
FBH1 protects melanocytes from transformation and is deregulated in melanomasYeon-Tae Jeong, Lukas Cermak, Maria V Guijarro, et al.
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Science (New York, N.Y.)|November 1, 2008
Cancer. Aneuploidy advantages?Eva Hernando
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2018
Characterization of MicroRNAs Regulating FOXO ExpressionDoug Hanniford, Eva Hernando
Nature Cell Biology|November 1, 2017
TYRP1 mRNA goes fishing for miRNAs in melanomaMaria S Soengas, Eva Hernando
Oncoimmunology|August 31, 2012
miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cellsAvital Gaziel-Sovran, Eva Hernando
Disease Models & Mechanisms|September 3, 2025
Modeling metastasis - leveraging novel tools to streamline discovery in advanced cancerNicole M Eskow, Eva Hernando
Cancers|December 11, 2022
Epigenetic Mechanisms Underlying Melanoma Resistance to Immune and Targeted TherapiesAndrey Rubanov, Pietro Berico, Eva Hernando
Cytometry|November 28, 2002
Separation of live cells in different phases of the cell cycle for gene expression analysisGloria Juan, Eva Hernando, Carlos Cordon-Cardo
Frontiers in Oncology|June 11, 2013
In vivo Modeling and Molecular Characterization: A Path Toward Targeted Therapy of Melanoma Brain MetastasisAvital Gaziel-Sovran, Iman Osman, Eva Hernando
Cancer|August 27, 2015
Revisiting determinants of prognosis in cutaneous melanomaSarah A Weiss, Douglas Hanniford, Eva Hernando, et al.
Cell Cycle (Georgetown, Tex.)|March 8, 2013
FBH1 protects melanocytes from transformation and is deregulated in melanomasYeon-Tae Jeong, Lukas Cermak, Maria V Guijarro, et al.
Pageof 12